Back
Aurinia Pharmaceuticals Stock Price Chart
Buy a stock when it crosses this line on the chart
Here's the line to follow.
Sell
45
AUPH
Aurinia Pharmaceuticals
Last Price:
5.46
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Free video reveals how to trade 1-day options
Get the free overnight options training here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
Aurinia Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.56 | Sell |
| 20-day SMA: | 5.49 | Sell |
| 50-day SMA: | 5.34 | Buy |
| 200-day SMA: | 6.83 | Sell |
| 8-day EMA: | 5.53 | Sell |
| 20-day EMA: | 5.49 | Sell |
| 50-day EMA: | 5.46 | Sell |
| 200-day EMA: | 6.65 | Sell |
Aurinia Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 48.77 | Sell |
| Chaikin Money Flow: | -479572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.32 - 5.58) | Sell |
| Bollinger Bands (100): | (4.81 - 6.13) | Sell |
Aurinia Pharmaceuticals Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 5.43 while AUPH 8-day simple moving average is 5.56, which is a Sell signal.
- The stock price of AUPH is 5.43 while Aurinia Pharmaceuticals 20-day SMA is 5.49, which makes it a Sell.
- Aurinia Pharmaceuticals 50-day simple moving average is 5.34 while AUPH share price is 5.43, making it a Buy technically.
- AUPH stock price is 5.43 and Aurinia Pharmaceuticals 200-day simple moving average is 6.83, creating a Sell signal.
AUPH Technical Analysis vs Fundamental Analysis
Sell
45
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a Sell
The current Aurinia Pharmaceuticals [AUPH] share price is $5.43. The Score for AUPH is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
776.6M
Price in USD:
5.43
Share Volume:
566.77K
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
12.43
52-Week Low:
4.71
Sell
45
Aurinia Pharmaceuticals (AUPH)
is a Sell
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?
The Aurinia Pharmaceuticals stock price is 5.43 USD today. -
Will AUPH stock go up or go down?
Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Aurinia Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 5.43 while AUPH 8-day exponential moving average is 5.53, which is a Sell signal.
- The stock price of AUPH is 5.43 while Aurinia Pharmaceuticals 20-day EMA is 5.49, which makes it a Sell.
- Aurinia Pharmaceuticals 50-day exponential moving average is 5.46 while AUPH share price is 5.43, making it a Sell technically.
- AUPH stock price is 5.43 and Aurinia Pharmaceuticals 200-day simple moving average is 6.65, creating a Sell signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
- AUPH Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Aurinia Pharmaceuticals is a Buy
- Aurinia Pharmaceuticals Relative Strength Index (RSI) is 48.77, which suggest Aurinia Pharmaceuticals is oversold
- The Bollinger Bands (25) for Aurinia Pharmaceuticals is (5.32 - 5.58), which suggest Aurinia Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Aurinia Pharmaceuticals is (4.81 - 6.13), which suggest Aurinia Pharmaceuticals is a Sell
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.